Inventor · disambiguated record
Maria Grazia Carr
Also filed as: CARR MARIA · CARR MARIA G · CARR MARIA GRAZIA
21 granted patents·8 pending applications·243 citations·filing 2003–2014
95Inventor score
Files withASTEX THERAPEUTICS LTD15BERDINI VALERIO7CHESSARI GIANNI3SAXTY GORDON3ASTEX TECHNOLOGY LTD1
Top patents by PatentIndex Score
29 records- 0196US7754725B2Dihydroxyphenyl isoindolymethanonesASTEX THERAPEUTICS LTD·Filed 2007·Granted Jul 13, 2010·22 cites·10 claims
- 0295US8106057B2Dihydroxyphenyl isoindolylmethanonesCHESSARI GIANNI·Filed 2010·Granted Jan 31, 2012·19 cites·7 claims
- 0395US7385059B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2006·Granted Jun 10, 2008·33 cites·20 claims
- 0492US8895745B2Bicyclic heterocyclic compounds as FGFR inhibitorsBERDINI VALERIO·Filed 2007·Granted Nov 25, 2014·33 cites·20 claims
- 0592US8101648B2Hydroxybenzamide derivatives and their use as inhibitors of HSP90CHESSARI GIANNI·Filed 2006·Granted Jan 24, 2012·20 cites·18 claims
- 0691US8110573B2Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinasesBERDINI VALERIO·Filed 2005·Granted Feb 7, 2012·9 cites·17 claims
- 0790US7977477B2Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2004·Granted Jul 12, 2011·35 cites·23 claims
- 0889US8530469B2Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90CHESSARI GIANNI·Filed 2011·Granted Sep 10, 2013·11 cites·21 claims
- 0988US7825140B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2007·Granted Nov 2, 2010·7 cites·19 claims
- 1088US7745638B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2007·Granted Jun 29, 2010·8 cites·23 claims
- 1187US8131527B1FGFR pharmacophore compoundsSAXTY GORDON·Filed 2007·Granted Mar 6, 2012·17 cites·47 claims
- 1287US8076354B2Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitorsSAXTY GORDON·Filed 2008·Granted Dec 13, 2011·9 cites·13 claims
- 1385US8080666B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsBERDINI VALERIO·Filed 2010·Granted Dec 20, 2011·6 cites·19 claims
- 1483US8513276B2Imidazo[1,2-a]pyridine compounds for use in treating cancerBERDINI VALERIO·Filed 2007·Granted Aug 20, 2013·8 cites·16 claims
- 1579US8778936B2Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinasesBERDINI VALERIO·Filed 2011·Granted Jul 15, 2014·2 cites·20 claims
- 1677US8779147B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsBERDINI VALERIO·Filed 2011·Granted Jul 15, 2014·2 cites·14 claims
- 1773US8796244B2Imidazopyridine derivatives as inhibitors of receptor tyrosine kinasesBERDINI VALERIO·Filed 2009·Granted Aug 5, 2014·2 cites·21 claims
- 1866US9914719B2Hydroxybenzamide derivatives and their use as inhibitors of HSP90ASTEX THERAPEUTICS LTD·Filed 2014·Granted Mar 13, 2018·0 cites·21 claims
- 1965US9051278B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Jun 9, 2015·0 cites·24 claims
- 2055US2014010892A1Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2013·Application pending·0 cites
- 2151US2011224203A1Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2011·Application pending·0 cites
- 2249US8859583B2Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitorsSAXTY GORDON·Filed 2011·Granted Oct 14, 2014·0 cites·20 claims
- 2345US2007082898A15 Amino-2-carbonylthiophene derivatives for use as p38 map kinase inhibitors in the treatment of inflammatory diseasesASTEX THERAPEUTICS LTD·Filed 2004·Application pending·0 cites
- 2443US2010160324A1Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinasesASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 2543US2006135516A13-(Carbonyl) 1h-indazole compounds as cyclin dependent kinases (cdk) inhibitorsASTEX TECHNOLOGY LTD·Filed 2003·Application pending·0 cites
- 2642US2008004270A13,4-Disubstituted Pyrazoles as Cyclin Dependent Kinases (Cdk) or Aurora Kinase or Glycogen Synthase 3 (Gsk-3) InhibitorsASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 2741US2007208015A15-Morpholinylmethylthiophenyl Pharmaceutical Compounds As P38 MAP Kinase ModulatorsASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 2839US2014288040A1Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infectionASTEX THERAPEUTICS LTD·Filed 2012·Application pending·0 cites
- 2938US9145354B2Pharmaceutical compoundsASTEX THERAPEUTICS LTD·Filed 2012·Granted Sep 29, 2015·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Maria Grazia Carr files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →